Abstract
Background: Chronic lymphocytic leukemia ,most common leukemia in western countries ,is characterized by accumulation of mature CD19,CD5,CD23 positive B cells. Indeed, microenvironments in the bone marrow, lymph node and other secondary lymphoid organs have been shown to inhibit spontaneous CLL cell apoptosis and enhance chemoresistance. Aim of the work: To study the clinical utility of CD184 in CLL patients,so that it can be used as routine investigation to predict the outcome of the disease and to help in choosing treatment regimen. Patients and methods: 33 newly diagnosed CLL patients at Nasser institute and Ainshams university hospitals, have undergone CBC , LFt, KFT; Virology, LDH,B2microglobulin, bone marrow aspiration and biobsy, immunophenotyping , cytogenetics, radiological investigation, And CD184 by flowcytometry which has been correlated with these diagnostic and prognostic parameters. Results: Positive correlation was found between CD184 and TLC, Lymphocytic count ,LDH,B2microglobulin,RAI stage and revised RAI score, while negative correlation was found between CD184 and both HB and platelet count. Conclusion: High CD184 expression associated with poor prognosis of CLL patients,so that it can be used as routine investigation to predict outcome of disease/
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Egyptian Journal of Hematology and Bone Marrow Transplantation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
